A Phase II Study of TACE Plus PD-1 Antibody in the Locally Advanced Stomach Adenocarcinoma

NCT04799548 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Transcatheter Arterial Chemoembolization
DRUG: Tislelizumab

Sponsor

Shanghai Zhongshan Hospital